03/18/14 - 07:17 PM EDT
Just over one year ago, when Allergan stood at about $115, worries abounded, causing the stock to drop to the low $80s by the middle of 2013, as the overall equity market continued to roar. This underperformance spooked many investors, but that low was a huge opportunity, as the stock has posted a stellar run ever since, now at new highs at over $130. I bring this up now because many are talking about a bubble in biotech, particularly given surges from recent IPOs.READ FULL POST
03/07/14 - 08:34 AM EST
All eyes are on the non-farm payroll numbers this morning, but take a look at some bizarre things happening in the U.S. economy right nowREAD FULL POST
03/06/14 - 08:43 AM EST
Costco is down this morning on a disappointing report. Check out this hidden camera capturing a debate over Costco's driversREAD FULL POST
03/05/14 - 05:28 PM EST
The company still hasn't recovered since its quarterly report. That is a gift and it is time to come into the stockREAD FULL POST
03/05/14 - 05:24 PM EST
Honeywell has mastered a five year plan that worksREAD FULL POST
03/04/14 - 03:51 PM EST
The latest disruptions in Ukraine and Russia are merely another reason to push for natural gas exportREAD FULL POST
02/26/14 - 09:37 AM EST
Forgiveness in retail is the story of the last five days. And with Abercrombie in particular, expectations came low enough to allow the stock to surgeREAD FULL POST
02/24/14 - 08:48 PM EST
The effect of weather lingers, but we will get a sense of company standing from guidanceREAD FULL POST
02/18/14 - 10:35 PM EST
The big news of today was Actavis' announcement o buy Forest Labs for $25 billion. And this is much more than just another win for Carl Icahn, the second largest holder of Forest Labs, which has gotten a lot of focus in media outlets.READ FULL POST
02/13/14 - 10:42 AM EST
Want to try to game these as a trade? Don't try - they are long-term winnersREAD FULL POST
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.